These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8952656)

  • 1. [Hereditary predispositions to cancer: the genetic diagnosis in practice].
    Girodet C; Vidal V; Laplace-Marieze V; Bignon YJ
    Bull Cancer; 1996 Sep; 83(9):764-8. PubMed ID: 8952656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Considerations for comprehensive assessment of genetic predisposition in familial breast cancer.
    Lynch H; Synder C; Wang SM
    Breast J; 2015; 21(1):67-75. PubMed ID: 25472498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hereditary breast cancer: high risk genes, genetic testing and clinical implications.
    Hamann U
    Clin Lab; 2000; 46(9-10):447-61. PubMed ID: 11034530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk assessment for familial occurrence of breast cancer].
    Chang-Claude J; Becher H; Hamann U; Schroeder-Kurth T
    Zentralbl Gynakol; 1995; 117(8):423-34. PubMed ID: 7571905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline alterations in the CLSPN gene in breast cancer families.
    Erkko H; Pylkäs K; Karppinen SM; Winqvist R
    Cancer Lett; 2008 Mar; 261(1):93-7. PubMed ID: 18077083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
    Chompret A
    J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic testing when tumor susceptibility, especially for colorectal cancer, is suspected].
    Müller H
    Ther Umsch; 2003 Aug; 60(8):445-53. PubMed ID: 14502851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary breast cancer.
    Ellisen LW; Haber DA
    Annu Rev Med; 1998; 49():425-36. PubMed ID: 9509273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hereditary predisposition for cancer of the breast and the ovary].
    Lalle P; Stoppa-Lyonnet D; Mazoyer S; Rio P; Girodet C; Hardouin A; Narod SA; Sobol H; Bignon YJ
    Bull Cancer; 1993 Oct; 80(10):857-65. PubMed ID: 8204923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.
    Lal G; Liu G; Schmocker B; Kaurah P; Ozcelik H; Narod SA; Redston M; Gallinger S
    Cancer Res; 2000 Jan; 60(2):409-16. PubMed ID: 10667595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic testing for cancer predisposition.
    Eng C; Hampel H; de la Chapelle A
    Annu Rev Med; 2001; 52():371-400. PubMed ID: 11160785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of the genetic predisposition to cancer in families of patients with multiple primary malignant neoplasms].
    Gar'kavtseva RF; Kazubskaia TP; Sel'chuk VIu
    Tsitol Genet; 1992; 26(2):32-6. PubMed ID: 1615556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA1 and BRCA2: from molecular genetics to clinical medicine.
    Blackwood MA; Weber BL
    J Clin Oncol; 1998 May; 16(5):1969-77. PubMed ID: 9586917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: where are we today?
    Cole DE; Gallinger S; McCready DR; Rosen B; Engel J; Malkin D
    CMAJ; 1996 Jan; 154(2):149-55. PubMed ID: 8548703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cell-type-specificity of inherited predispositions to tumours: review and hypothesis.
    Bignold LP
    Cancer Lett; 2004 Dec; 216(2):127-46. PubMed ID: 15533589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
    Lerman C; Hughes C; Lemon SJ; Main D; Snyder C; Durham C; Narod S; Lynch HT
    J Clin Oncol; 1998 May; 16(5):1650-4. PubMed ID: 9586874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
    Kuschel B; Lux MP; Goecke TO; Beckmann MW
    Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.